Correlation Between Enveric Biosciences and NLS Pharmaceutics

Can any of the company-specific risk be diversified away by investing in both Enveric Biosciences and NLS Pharmaceutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Enveric Biosciences and NLS Pharmaceutics into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Enveric Biosciences and NLS Pharmaceutics AG, you can compare the effects of market volatilities on Enveric Biosciences and NLS Pharmaceutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Enveric Biosciences with a short position of NLS Pharmaceutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Enveric Biosciences and NLS Pharmaceutics.

Diversification Opportunities for Enveric Biosciences and NLS Pharmaceutics

0.32

Correlation Coefficient

Enveric Biosciences  NLS Pharmaceutics

Weak diversification

The 3 months correlation between Enveric and NLS is 0.32. Overlapping area represents the amount of risk that can be diversified away by holding Enveric Biosciences and NLS Pharmaceutics AG in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on NLS Pharmaceutics and Enveric Biosciences is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Enveric Biosciences are associated (or correlated) with NLS Pharmaceutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of NLS Pharmaceutics has no effect on the direction of Enveric Biosciences i.e., Enveric Biosciences and NLS Pharmaceutics go up and down completely randomly.

Pair Corralation between Enveric Biosciences and NLS Pharmaceutics

Given the investment horizon of 90 days Enveric Biosciences is expected to under-perform the NLS Pharmaceutics. In addition to that, Enveric Biosciences is 1.52 times more volatile than NLS Pharmaceutics AG. It trades about -0.06 of its total potential returns per unit of risk. NLS Pharmaceutics AG is currently generating about 0.02 per unit of volatility. If you would invest  182.00  in NLS Pharmaceutics AG on December 27, 2024 and sell it today you would lose (29.00) from holding NLS Pharmaceutics AG or give up 15.93% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Very Weak
Accuracy	100.0%
Values	Daily Returns

Enveric Biosciences  vs.  NLS Pharmaceutics AG

Enveric Biosciences

Risk-Adjusted Performance

Very Weak

Over the last 90 days Enveric Biosciences has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in April 2025. The current disturbance may also be a sign of long term up-swing for the company investors.

NLS Pharmaceutics

Risk-Adjusted Performance

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in NLS Pharmaceutics AG are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. Even with relatively unfluctuating basic indicators, NLS Pharmaceutics may actually be approaching a critical reversion point that can send shares even higher in April 2025.

Pair Trading with Enveric Biosciences and NLS Pharmaceutics

The main advantage of trading using opposite Enveric Biosciences and NLS Pharmaceutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Enveric Biosciences position performs unexpectedly, NLS Pharmaceutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in NLS Pharmaceutics will offset losses from the drop in NLS Pharmaceutics' long position.

The idea behind Enveric Biosciences and NLS Pharmaceutics AG pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Efficient Frontier module to plot and analyze your portfolio and positions against risk-return landscape of the market..